Principal Investigator
Kamil Detyniecki
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250295
Clinical Trial Summary
A Double-Blind, Randomized, Placebo-Controlled,
Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures
Phase
Phase II
Funding Agency/Sponsor
Other
Disease
Epilepsy
Contact Information
Study Contact
Klenisson Brenner
Phone Number
+1 (305) 2431322
Email
kxb1280@miami.edu